Literature DB >> 26377227

Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction?

Stephen J Greene1, Gregg C Fonarow2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26377227     DOI： 10.1002/ejhf.337

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  3 in total

1.  Ginsenoside Rg3 ameliorates myocardial glucose metabolism and insulin resistance via activating the AMPK signaling pathway.

Authors:  Jingyu Ni; Zhihao Liu; Miaomiao Jiang; Lan Li; Jie Deng; Xiaodan Wang; Jing Su; Yan Zhu; Feng He; Jingyuan Mao; Xiumei Gao; Guanwei Fan
Journal:  J Ginseng Res       Date:  2021-06-05       Impact factor: 5.735

Review 2.  Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.

Authors:  Wynn G Hunter; Jacob P Kelly; Robert W McGarrah; William E Kraus; Svati H Shah
Journal:  Curr Heart Fail Rep       Date:  2016-06

3.  Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction.

Authors:  Michael Coll Barroso; Frank Kramer; Stephen J Greene; Daniel Scheyer; Till Köhler; Martin Karoff; Melchior Seyfarth; Mihai Gheorghiade; Wilfried Dinh
Journal:  BMC Cardiovasc Disord       Date:  2016-10-21       Impact factor: 2.298
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.